New Hope for Survivors of Stroke and Traumatic Brain Injury
- 144 Downloads
In mid-2010, an editorial marking the 40th anniversary of the International Journal of Stroke was signed by over 50 leaders in the field. It provided a frank commentary on what they regarded as the inability of present mainstream stroke research directions to address the needs of patients . In view of what they described as a dearth of advances leading to new targets for therapy, they urged their field to break down its silo mentality and embrace new ideas and approaches from other scientific disciplines and diseases. In short, to listen to outsiders and through them learn to think outside the box.
A paper in this issue of CNS Drugsby Tobinick et al. might well have provided them such an opportunity. In more than 600 consecutive stroke patients, years after the initial ischaemic insult, highly significant improvements in a large range of clinical parameters were recorded at 30 min, 1 week and 3 weeks after a single dose of 25 mg of etanercept. A smaller number of patients who had...
KeywordsTraumatic Brain Injury Etanercept Fibrinolytic Enzyme Stroke Event Ischaemic Insult
No sources of funding were received to prepare this article. The author has no conflicts of interest that are directly relevant to the content of this article.
- 2.Tobinick EL, Gross H, Weinberger A, et al. TNF-alpha modulation for treatment of Alzheimer’s disease: a 6-month pilot study. MedGenMed Neurol Neurosurg. 2006;8(2):25.Google Scholar
- 9.Simpkins JW, Gatson JW, Wigginton JG. Commentary on “a roadmap for the prevention of dementia II. Leon Thal Symposium 2008.” Rationale and recommendations for first evaluating anti-Alzheimer’s disease medications in acute brain injury patients. Alzheimers Dement. 2009;5(2):143–6.PubMedCrossRefGoogle Scholar